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ABSTRACT
Subtle changes in Raman spectral line-shape have been observed from malignant human brain cells and its
possibility for being used in detection and grading of Glioma has been explored here. The latter has been
developed as a result of the fact that the width of the Raman spectra is more sensitive, as compared to the
peak position, to the brain tumors. The perturbations induced by the cell-modification, as a consequence to
the cancerous growth, may be responsible for the widths variation in the Raman spectrum due to vibrational
lifetime alteration enforced at the molecular levels. A consistent cancer induced effect on the spectral width
has been observed for three different brain cells Raman modes at frequencies 1001 cm−1, 1349 cm−1 and 1379
cm−1. Raman spectral analysis reveals that for cancerous cells, the FWHM varies up to 35 % in comparison
with the healthy cells. It has been established how a careful analysis of Raman spectra can help in easy
detection of brain tumors. The methodology has been validated by studying the effect of similar microscopic
perturbations, e.g, Fano coupling and quantum size effects, on different Raman spectral parameters which
also reveals Raman width to be the most sensitive parameter.
Keywords: Glioma; Raman line-shape; Fano coupling; quantum confinement
1
ar
X
iv
:2
00
5.
02
63
8v
1 
 [p
hy
sic
s.a
pp
-p
h]
  6
 M
ay
 20
20
1 Introduction
Raman scattering[1,2], since its discovery in 1928, has now been established as a spectroscopic technique[3-6]
having many applications in different fields of science, engineering and technology[7,8]. Beyond identification
of bond modes, a Raman spectrum is capable of investigating several materials properties if analysed under
appropriate framework. Mode identification can be done by indexing the Raman peak positions but it
may contain lot more information than simple chemical bonds energies which may also be investigated
using IR spectroscopy, of course with certain limitations. Beyond the peak position of a Raman peak,
the overall line-shape of the spectrum is equally important as it may reveal several important physical
phenomena taking place at microscopic level like quantum confinement or size effect, electron-phonon effect,
fantum effect etc[9-16]. Apart from direct evidences, as a consequence of Raman line-shapes sensitivity
towards external conditions, perturbations induced by temperature, pressure etc also can be investigated
using classical and advanced Raman techniques[17-21]. The external perturbations like temperature, pressure
etc. induce the Raman line-shape to alter by means of change in its peak position, width, asymmetry etc as
compared to unperturbed condition. These perturbation induced line-shape changes have allowed Raman
spectroscopy to be used in bioscience as a diagnostic tool. In biosciences, Raman spectroscopy also bears
certain advantages over IR spectroscopy due to involvement of water molecules in cells which do not hinder
Raman scattering unlike IR spectroscopy. Still there is a scope for Raman spectroscopy to be used to its full
potential through careful analysis of subtler changes in the Raman spectra from biological samples suffering
from infections/malignancies[3,22-28].
According to a report of the World Health Organisation, cancer is the second leading cause of death
globally and is responsible for an estimated 9.6 M deaths in 2018 with about 1 in 6 deaths take place due to
cancer[29]. As known, cancer is the transformation of normal cells into cancerous cells in a multistage process
that generally progresses from a pre-cancerous lesion to a malignant tumour. Gliomas are the most common
primary brain tumors characterized by diffuse infiltration and aggressiveness.. The presence of an isocitrate
dehydrogenase (IDH) mutation was first discovered in colorectal cancers. Parsons et al. [30] found mutations
of the IDH1 in 12 % of the glioblastomas (GBMs)[3134]. Other large scale studies have also validated that
IDH1 and IDH2 mutations were found in the majority of secondary GBM and lower grade gliomas like
diffuse astrocytomas (DA), while these were rarely found in adult primary and pediatric GBMs. Looking
at the cancer related fatalities, it is important to diagnose the disease early so that necessary therapeutic
interventions can be initiated for optimum patient care. In the last couple of decades, classic and advanced
Raman spectroscopic techniques like surface enhanced and Fourier transform Raman spectroscopy have been
used widely with the latter having certain advantages[3238]. Raman spectroscopy enables one to retrieve a
molecular signature of tissues biochemical composition in order to identify tumor and normal tissue, and in
conjunction with different statistic algorithms, the spectral data with various pathologic attributions can be
differentiated and classified depending on their spectral differences, e.g., peak area, peak height or peak- or
spectral line shape. This makes Raman spectroscopy a very efficient analytical technique for rapid and non-
destructive diagnosis of human diseases like cancer. One of the drawbacks in using Raman spectroscopy lies
with the tedious spectral analysis involved. This limits the techniques applicability. A simpler methodology
can be developed for the analysis of Raman spectra for easier application in detection of disease which can
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be done as follows. Disease, an infection or malignancies, can be considered as a transformation of a healthy
cell into a deformed state due to an external invasion or unwanted change at the cellular levels. The extent
up to which the invasion or malignancy has taken place will affect the healthy cell accordingly. Since the cells
are a combination of molecular bonds, any change in terms of infection/malignancy will certainly perturb
the molecular structure and thus is expected to manifest itself in the corresponding Raman spectrum. The
modification in the Raman spectra, by means of change in its peak position, width, asymmetry etc, thus
can be used to identify the nature and quantum of invasion/malignancy after simpler calibrations. This
can be used for identification of disease by simple analysis of Raman spectra without going into tedious
methodology like principle component analysis.
The aim of the present article is to suggest a methodology to develop a simpler analytical approach to
use Raman spectroscopy as a diagnostic tool for identification and grading of brain cancer. For this purpose,
Raman spectra from known samples of malignant human brain cells have been recorded and compared with
corresponding normal (healthy) counterpart for analysis of the difference between the two sets of samples.
The known cases of gliomas have been established using traditional biopsy samples with histopathological
and immonohistochemical analysis.. From the samples, on which the disease has been confirmed, only subtle
changes in Raman spectral width has been observed and found sufficient to establish and grade the presence
of cancer. The methodology has been validated by studying a perturbation induced Raman spectral changes
in a known silicon (Si) nanowires systems. Three different types of perturbations in terms of Fano coupling
and quantum confinement effects have been investigated to reveal that Raman spectral width remains the
most sensitive parameter to get affected by subtle perturbations. This is similar to the biological observations
and thus helps establishing the proposed methodology for disease diagnosis and grading.
2 Experimental Details
Samples comprised biopsies of patients presenting with intracranial mass lesions to Safdarjung Hospital,
New Delhi, India. Histopathological examination of biopsy material was performed at National Institute
of Pathology, New Delhi. Hematoxylin and eosin staining was done followed by immunohistochemistry for
IDH 1 mutation. Optical microscope (Nikon) was used for histopathological analysis. The morphological
images of the samples were observed by fluorescence inverted microscope (NikonTM make) under ambient
condition using Differential Interference Contrast (DIC) for two malignant samples as well as the healthy
sample used as control. The three samples included normal brain, Diffuse Astrocytoma IDH-mutant, Grade
II and Glioblastoma IDH- wild type, Grade IV. Grading was done according to WHO Classification of
Central Nervous system tumors (2016). Raman spectra from all of these samples have been recorded using
Horiba-JobinYvon (Labram-HR) spectrometer using 633 nm excitation source in back scattering geometry.
The Raman width analyses have been done by carrying out a Gaussian fitting of the Raman spectra from
which the experimental widths have been estimated for rest of the study.
3
Figure 1: Optical microscopic images from (a) Diffuse astrocytoma (IDH-mutant) (WHO Grade II), (b)
Glioblastoma (GBM, IDH wildtype) (WHO Grade IV) and (c) of the normal brain tissue sample (no tumor
present).
3 Results and Discussion
For diagnosis and grading of tumors, the biopsy samples were subjected to histopathological examination.
The H & E stained slides were viewed under an optical microscope (Figure 1a, 1b) and the same were
compared with the normal brain parenchyma (Figure 1c). The IDH mutation analysis was done by immuno-
histochemistry using Anti IDH-1 antibody (Dianova). The samples were classified as Diffuse astrocytoma,
IDH- mutant (DA) (Figure 1a), Glioblastoma, IDH- wildtype (GBM) (Figure 1b) and normal brain (Fig-
ure 1c). These terminologies DA, IDH mutant, GBM and Normal will be used for Diffuse Astrocytoma,
Isocitrate Dehydrogenase mutant, Glioblastoma IDH wildtype and normal brain parenchyma respectively
throughout the manuscript.
Observation of distinct morphologies from different grade cells (Figure 1) clearly suggests different mi-
crostructures at the microscopic level. Since these cells are composed of different molecules thus subtle
changes must have taken place at micro-level. If these changes can sufficiently perturb the physical nature
of the cells, which is actually likely from Figure 1, the same must be observable in Raman spectra. Keeping
the above hypothesis in mind, Raman spectra from these samples have been recorded (Figure 2). Raman
spectra from all the samples exhibited three modes around ∼1001 cm −1 (mode of protein) , 1349 cm −1
(mode of nucleic acid) and 1379 cm −1 (mode of lipids) which is consistent with the literature [23] and have
been identified for detailed Raman analyses. The Raman peak position of all these modes remain unchanged
even from the malignant cells. This immunity of Raman peak position with respect to the presence of disease
means that the disease induced perturbations are not sufficient to change the frequency of the corresponding
molecular vibrations and are rather subtle in nature if at all present. A closer analysis reveals that the full
width at half maximum (FWHM) of the protein mode (1001 cm−1) varied significantly by 37% (decrease)
for DA, IDH mutant as well as GBM stages of the disease, as compared to the normal samples for which
the Raman mode was 8 cm−1 wide that reduces to 5 cm−1 for the disease stages (Figure 2b). Similar trend
was also observed for the nucleic acid and lipid modes (Figure 2c) with non varying frequencies at 1349 cm
−1 and 1379 cm −1 respectively. Trend in disease dependent width variation was observed for these two
modes (Figure 2d) showing ∼13.8 % change (increase) in mode width for DA IDH mutant and ∼2% change
(decrease) in mode width for GBM case as compared to normal cells where the width was 32.5 cm−1 for the
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Figure 2: Raman spectra from different samples showing (a) the 1001 cm−1 phenylalanine mode and com-
parison of the observed FWHM values (b); (c) the nucleic acid, 1349 cm−1 and lipid, 1379 cm−1 modes along
with the comparative FWHM variation (d).
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1349 cm−1 mode (black bars, Figure 2d). On the other hand, the 1379 cm−1 mode showed an increase (de-
crease) of 15.7% in FWHM for IDH (GBM) disease stages as compared to the 28.5 cm−1 wide Raman mode
(red bars, Figure 2d) from healthy cells. The results were found consistent, in terms of unchanged peaks
position and varying FWHM, for all the three modes analyses done with a sample size of 25. The obtained
results, the disease dependent variation in only the FWHM with mode frequency remaining unaffected, are
unprecedented. Such a disease dependent observation in Raman width can be useful in identifying and grad-
ing the disease, due to consistent results, but needs validation and explanation of such observation. In other
words, if significant and consistent changes in FWHM are observed, it can be assigned due to malignancy if
other infections have been ruled out.
As mentioned above, the sole variation of the Raman mode, with little effect in the peak position, clearly
indicated that the disease dependence perturbation is subtle in nature i.e, it is not sufficient to change the
frequency of the corresponding molecular vibration. The exclusive variation in the width could be likely
due to the malignant induced change in the vibrational life time of the cancerous cell. This has been
validated by taking an example of Raman line-shape variation as a result of systematic perturbation in a low
dimensional solid state semiconductor system. Raman line-shape analysis has been done from a very well
known semiconductor system, Si, where quantum confinement effect and electron-phonon (Fano) interaction
have been used as known control perturbations and will be discussed one-by-one for validation. For this
purpose, the theoretical Raman line-shapes have been generated using the universal perturbation dependent
Raman line-shape function developed earlier by Richter et al[39] and later modified by Campbel et al[40,41]
and several others[5,6,10,15,42-46]. The simplified general equation for universal Raman line-shape can be
represented by Eq. 1 below:
I(ω) =
∫ 1
0
e−
k2L2
4a2
[
(+ q)2
1 + 2
]
dnk (1)
where,  = ω−ω(k)γ/2 , D, a, γ denote the nanocrystallite size, lattice constant and line width ( ∼ 4 cm−1) of
Si respectively. Here n=2 is the degree of quantum confinement for the case of SiNWs. The ω2(k) = 171400
+ 100000 cos (pik/2)) is the phonon dispersion relation for Si and ‘q is the Fano asymmetry parameter which
is the measure of extent of Fano interaction present in the system. To see the effect of Fano coupling on
line-shape variation, the line-shape generated using different ‘q values between -3 to -10 have been analyzed
(Figure 3a) representing a donor-type discrete-continuum Fano interference [14,4345,47]12,3840,42 for a given
crystallite size of 3 nm. The obtained theoretical line-shapes are broad and asymmetric (as compared to
crystalline Si counterpart which is sharp and symmetric[4,6,46] in nature as a consequence of the classic
discrete-continuum (Fano-) interaction[48]44. Figure 3a clearly shows that the Raman line-shape becomes
more and more asymmetry when the absolute value of q reduces (due to increase in Fano coupling). The
line-shape asymmetry is quantified using the term asymmetry ratio (α) defined by the ration α = γl/ γh,
where γl and γh are the spectral half widths of the line-shape towards the lower and higher energy side of
the Raman peak position respectively. It is apparent that with changing q values, the width, γ (= γl +
γh) as well as the peak position (ω) both changes but not at the same rate (with respect to q). The rate
of change of and has been plotted as a function of q in Figure 3b which shows that the FWHM changes
more rapidly as compared to the peak position (i.e, dγ/dq > dω/dq). In physical terms, it means that the
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Figure 3: (a) Theoretical Raman line shapes generated using Eq. 1 for different values of Fano coupling
parameter q and crystallite size D = 3 nm, (b) Rate of change of variation of width and Raman peak shift
as a function of Fano parameter showing width being the fastest varying parameter for donor type Fano
coupling system
Raman spectral width is more sensitive to the micro level perturbation induced by donor type Fano coupling.
This behavior is similar to the one discussed above (Figure 2) where Raman spectral width exhibits change
without affecting the peak position which is expected to change only after the perturbation is of sufficient
quantum. This is also apparent from Figure 3b where the peak position does not change until a large Fano
coupling is present whereas the width starts responding to the perturbation relatively earlier.
Before concluding the above-mentioned observation, the Fano parameter dependent Raman spectral line-
shape variation has been studied for an acceptor type discrete-continuum Fano coupling as shown in Figure
4a and corresponding rate of change of line-shape parameters has been shown in Figure 4b. However,
this system is known to be complementary to the case discussed in Figure 3, the sensitivity of the width
remains prominent as compared to the peak position or asymmetry ratio here too. It further endorses the
conclusions drawn above that Raman spectral line width (γ) remains the most sensitive parameter which
starts responding to even subtle perturbations whereas stronger perturbations are needed to be reflected
in other Raman line-shape features like peak position. This further affirms that the disease induced width
variation can potentially be used to identify presence of malignancy in cells. Furthermore, to validate the
above-said fact (the FWHMs sensitivity to subtle perturbation) another perturbation, of completely different
in nature, the quantum confinement (or size-) effect, has also been considered as described somewhere else
in great detail[49]. For this analysis, Raman line-shapes obtained corresponding to different Si nanowires
size have been analyzed[49] with no Fano effect. With decrease in size, effect on Raman peak position and
FWHM becomes prominent (Figure 5a) with the latter varying more rapidly as evident from the derivative
plot in Figure 5b.
Three different perturbations, donor type Fano interference (Figure 3), acceptor type Fano interference
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Figure 4: (a) Theoretical Raman line shapes generated using Eq. 1 for different values of Fano coupling
parameter q and crystallite size D = 3 nm, (b) Rate of change of variation of width and Raman peak shift
as a function of Fano parameter showing width being the fastest varying parameter for acceptor type Fano
coupling system.
Figure 5: (a) Variation of Raman peak position and width as a function of crystallite size, obtained using
Eq. 1 using phono confinement model and (b) Rate of change of variation of width and Raman peak shift as
a function of size showing width being the fastest varying parameter for systems with quantum confinement
effect.
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(Figure 4) and quantum confinement effect (Figure 5) [49] reveal consistently that all these microscopic level
perturbations can affect the Raman spectral widths even with their minimum possible presence. On the
other hand, stronger perturbations are necessary to induce changes in the Raman peak position. In other
words, a change in Raman spectral width (γ) with little associated changes in other Raman parameters, in
a system can be observed due to subtle changes at microscopic level in a system and the same should not
be neglected as it may contain important information. Since the malignancy can be considered analogous to
these perturbations, thus the malignancy induced modifications observed in the spectral widths from human
brain cells are sufficient to assign the changes due to the developement of glioma in the patient and thus
in fact can be used as a diagnostic tool for identification and grading of the disease. It also opens up a
possibility to explore the use of this simple observation as a tool for early detection of cancer without going
into tedious Raman spectroscopic analysis.
4 Conclusions
Raman spectroscopic studies from human brain cells, suffering from Glioma, duly diagnosed using traditional
methods from the biopsy samples, shows variations in spectral widths with little effect on the Raman peak
positions as compared with the healthy cells. The above mentioned variations have been observed as a result
of malignancy induced perturbations at the molecular level. The protein, lipid and nucleic acid Raman
vibrational modes width change by upto ∼38% from the malignant cells as compared to the healthy cells.
Above observations can be used for identification and grading of the disease in a simpler manner as the results
have been validated using a nanostructured system where these subtle perturbations are observed to be
inducing changes in the width as it is the most sensitive parameter to get affected by minimal perturbations.
Effect of donor- and acceptor- type continuum-discrete interaction and quantum dimensional size on Raman
spectral parameters confirms that spectral width is the most sensitive parameter to any subtle perturbations.
This helps in deducing and validating the fact that the malignancy actually acts as a physical cause to induce
enough perturbation to affect the phonon life time of the molecular level to be reflected in the width and
thus can be used for disease detection and staging using the simpler Raman spectroscopy based technique.
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